City

Nashville (1)

San Francisco (1)

Condition

Angiotensin Receptor Blockers (2)

Angiotensin Converting Enzyme (1)

Angiotensin-converting Enzyme Inhibitor (1)

Blood Pressure (1)

Cardiopulmonary Bypass (1)

Chronic Kidney Disease (1)

Coronary Artery Disease (1)

Fibrinolysis (1)

Inflammation (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Sign in for free

Phase

n/a (1)

phase 4 (1)

Sponsor

University of California, San Francisco (1)

Vanderbilt University (1)

Collaborator

Intervention

candesartan (1)

continuation of acei and/or arbs (1)

placebo (1)

ramipril (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Other (2)

Study Type

Interventional (2)

angiotensin receptor blockers

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Chronic Kidney Disease, Blood Pressure, Angiotensin-converting Enzyme Inhibitor Trial in San Francisco (Continuation of ACEi

Active, not recruiting

Chronic Kidney Disease
+3 more

Continuation of ACEi and/or ARBs

San Francisco, California

University of California, San Francisco

Oct 4, 2021

Coronary Artery Disease, Angiotensin Converting Enzyme, Angiotensin Receptor Blockers Trial in Nashville (Placebo, Ramipril,

Completed

Has Results

Coronary Artery Disease
+5 more

Placebo
+2 more

Nashville, Tennessee
+1 more

Sep 7, 2012